Skip to main content
Signal8

Electromed, Inc. (ELMD)

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

Sector: Electromedical & Electrotherapeutic Apparatus

Industry: Medical - Devices

Electromed, Inc. logo

Electromed, Inc.

NYSE:ELMDHealthcare
+0.15%$26.66
AH$26.66+0.00%vs close
Mkt Cap$223.04M
Float6.59M
O/S8.37M
Inst Own56.5%
Dilution
FormDescription
DEF 14A
Definitive Proxy Statement
3
DEFA14A
Additional Proxy Materials
ARS
SEC Filing
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
8-K
10-K
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
144
Notice of Proposed Sale of Securities
144
Notice of Proposed Sale of Securities
SD
SEC Filing
4
Statement of Changes in Beneficial Ownership
144
Notice of Proposed Sale of Securities
10-Q
8-K
2.02,7.01,9.01
UPLOAD
SEC Filing
13G/A
Beneficial Ownership Report (Amended)
CORRESP
SEC Filing
UPLOAD
SEC Filing
1
10-Q
Quarterly Report
8-K
2.02,7.01,9.01
8-K
1.01,2.03,9.01
4
Statement of Changes in Beneficial Ownership

1-25 of 578

…